The long-term outcome of childhood nephrotic syndrome in Germany: a cross-sectional study
- 27 Downloads
Long-term outcomes of children with nephrotic syndrome have not been well described in the literature.
Cross-sectional study data analysis of n = 43 patients with steroid-sensitive (SSNS) and n = 7 patients with steroid-resistant (SRNS) nephrotic syndrome were retrospectively collected; patients were clinically examined at a follow-up visit (FUV), on average 30 years after onset, there was the longest follow-up period to date.
The mean age at FUV was 33.6 years (14.4–50.8 years, n = 41). The mean age of patients with SSNS at onset was 4.7 years (median 3.8 years (1.2–14.5 years), the mean number of relapses was 5.8 (0 to 29 relapses). Seven patients (16.3%) had no relapses. Eleven patients were “frequent relapsers” (25.6%) and four patients still had relapses beyond the age of 18 years. Except of cataracts and arterial hypertension, there were no negative long-term outcomes and only one patient was using immunosuppressant therapy at FUV. 55% of patients suffered from allergies and 47.5% had hypercholesterolemia. Two patients suffered a heart attack in adulthood. A younger age at onset (< 4 years) was a risk factor for frequent relapses. An early relapse (within 6 months after onset) was a risk factor and a low birth weight was not a significant risk factor for a complicated NS course. The mean age of patients with SRNS at onset was 4.6 ± 4.4 years and 27.5 ± 9.9 years at FUV. Three patients received kidney transplantations.
The positive long-term prognosis of SSNS can reduce the concern of parents about the probability of the child developing a chronic renal disease during the clinical course after onset.
KeywordsChildhood nephrotic syndrome Steroid-sensitive nephrotic syndrome Steroid-resistant nephrotic syndrome Outcome Complication
Body mass index
Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland
Focal segmental glomerulosclerosis
Minimal change nephrotic syndrome
Steroid-sensitive nephrotic syndrome
Steroid-resistant nephrotic syndrome.
***Ingo Franke †*** We thank our first author, colleague, and friend Ingo Franke for his excellent work in the field of Pediatric Nephrology in Germany. He taught us very enthusiastically, and he was a great pediatrician and researcher. Rest in Peace, dear Ingo! This publication should confirm your effort, your invested time, and energy. We all miss you!
IF and RH designed and performed the study. MA, MB, LK, RH, and IF performed the literature search, extracted data, and drafted the manuscript. ML and RG participated in manuscript writing and revision. All authors have read and approved the final manuscript.
This study was not funded by any private or institutional organizations/firms.
Compliance with ethical standards
Conflict of interest
The authors have declared that they have no competing interests. This work has not been published before and it is not under consideration for publication anywhere else. Its publication has been approved by all co-authors.
Ethics approval and consent to participate
All retrospectively and prospectively analyzed data involving human participants were in accordance with the ethical standards and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical approval was obtained by the Ethics Committee of the Faculty of Medicine, Rheinische Friedrich-Wilhelms-University, Bonn, Germany, and the study was assigned the human study registration number 081/05. The data extraction and analyses were performed pseudonymously; an additional participant informed consent was obtained from all individual participants included in the study. This article does not contain any studies with animals performed by any of the authors.
- 2.Nash MA, Edelmann CM Jr, Bernstein J, Barnett HL. Minimal change nephrotic syndrome, diffuse mesangial hypercellularity and focal glomerulosclerosis. In: Edelmann CM Jr, editor. Pediatric kidney disease. 2nd ed. Boston: Little, Brown; 1992. pp. 1267–90.Google Scholar
- 3.Hussain N, Zello JA, Vasilevska-Ritovska J, Banh TM, Patel VP, Patel P, et al. The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome. BMC Nephrology. 2013;14:25. https://doi.org/10.1186/1471-2369-14-25.CrossRefGoogle Scholar
- 5.Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res. 2005;122:13–28.Google Scholar
- 7.Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol. 1997;8:769–76.Google Scholar
- 8.Broyer M, Meyrier A, Niaudet P, Habib R. Minimal changes and focal segmental glomerular sclerosis. In: Davison AM, editor. Oxford textbook of clinical nephrology. 2nd ed. Vol. 1. Oxford: Oxford university Press; 1998. pp. 493–535.Google Scholar
- 15.Schwartz MW, Schwartz GJ, Cornfeld D. A 16 year follow up study of 163 children with nephrotic syndrome. Pediatrics. 1974;54:548–52.Google Scholar
- 44.Brocklebank JT, Harcourt RB, Meadow SR. Corticosteroid-induced cataracts in idiopathic nephrotic syndrome. Arch Dis Childhood. 1982;53:30–4.Google Scholar